Safety considerations of a new anti-CMV cellular therapy - experience from donor-derived, directly selected, adoptively transferred T cells (Cytovir (TM) CMV) in 2 randomized clinical trials

BONE MARROW TRANSPLANTATION(2015)

Cited 0|Views5
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined